Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Riccardo Maria Inciardi, MD, PhD
When and Why to Use CAC Scoring
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Target in Sight: Escalating Therapy to Reach LDL-C Goals
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
Bridging ASCVD Care Between Academic and Rural Settings
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Managing Patients With AAV in the Rheumatology Clinic
Trade off: Ischemic/Thrombotic vs Bleeding
Renato D. Lopes, MD, MHS, PhD
Setting the Stage of Real-World Data vs RCT
Patient Case Study: Obesity
Valeria Caso, MD, PhD
Optimizing AAV Outcomes: Maintenance Therapies
Silke R. Brix, MD, MRCP, SCPR
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.